Related Experiment Video
Updated: Aug 14, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Structural Misalignment Between Regulatory Definitions of BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer and
1Health & Life Sciences, Shiroito Co., Ltd., Tokyo 107-0061, Japan.
Healthcare (Basel, Switzerland)
|August 13, 2026
Summary
Current definitions for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) are difficult to apply in practice. Real-world healthcare structures often prevent patients from meeting criteria for adequate Bacillus Calmette-Guérin (BCG) treatment and surveillance.
Area of Science:
- Urology
- Oncology
- Health Services Research
Background:
- Definitions of BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) are crucial for treatment decisions and clinical trial eligibility.
- Current definitions depend on prerequisites like adequate BCG exposure and maintenance therapy, which are not consistently met in diverse healthcare settings.
Purpose of the Study:
- To examine structural and operational factors limiting the applicability of current BCG-unresponsive criteria in real-world NMIBC care.
- To compare operational assumptions in definitions with actual treatment patterns.
Main Methods:
- A multilevel analysis integrating regulatory frameworks, national claims data, multicenter studies, and practice observations.
- Categorization of structural barriers across macro, meso, and micro levels of healthcare systems.
Main Results:
- Many patients cannot be classified under existing criteria due to unmet exposure-based and time-dependent conditions.
- Infrequent maintenance BCG, variable surveillance, limited radical cystectomy access, and missing data hinder classification.
- Classification failures stem from unmet structural assumptions, not tumor biology or clinician behavior.
Conclusions:
- Existing BCG-unresponsive criteria rely on structural conditions not universally present in real-world NMIBC care.
- Context-specific operational definitions and improved healthcare infrastructure are needed.
- Strategies include enhancing guideline implementation, data completeness, surveillance standardization, and healthcare infrastructure to align expectations and improve access to bladder-sparing therapies.
